BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 26662618)

  • 1. Pelvic exenteration for advanced malignancy in elderly patients.
    Radwan RW; Evans MD; Davies M; Harris DA; Beynon J;
    Br J Surg; 2016 Jan; 103(2):e115-9. PubMed ID: 26662618
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Determinants of survival following pelvic exenteration for primary rectal cancer.
    Radwan RW; Jones HG; Rawat N; Davies M; Evans MD; Harris DA; Beynon J;
    Br J Surg; 2015 Sep; 102(10):1278-84. PubMed ID: 26095525
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pelvic exenteration: a critical analysis of a ten-year experience with the use of the team approach.
    Galante M; Hill EC
    Am J Obstet Gynecol; 1971 May; 110(2):180-9. PubMed ID: 5574622
    [No Abstract]   [Full Text] [Related]  

  • 4. Pelvic exenteration for men with locally advanced rectal cancer: a morbidity analysis of complicated cases.
    Hsu TW; Chiang FF; Chen MC; Wang HM
    Asian J Surg; 2011 Jul; 34(3):115-20. PubMed ID: 22208686
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factors affecting outcomes following pelvic exenteration for locally recurrent rectal cancer.
    PelvEx Collaborative
    Br J Surg; 2018 May; 105(6):650-657. PubMed ID: 29529336
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ileal neobladder for urinary bladder replacement following total pelvic exenteration for rectal carcinoma.
    Yamamoto S; Yamanaka N; Maeda T; Uchida Y; Yabe S; Nakano M; Sakano S; Yamada Y; Takenaka A; Yamamoto M
    Dig Surg; 2001; 18(1):67-72. PubMed ID: 11244263
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pelvic exenteration: long-term oncological results in a series of 106 patients.
    De Wever I
    Acta Chir Belg; 2011; 111(5):282-7. PubMed ID: 22191128
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Urinary complications of pelvic exenterations for rectal cancer with urinary invasion].
    Gas J; Beauval JB; Chalret du Rieu M; Bou Nasr E; Philis A; Kirzin S; Thoulouzan M; Soulié M; Ghouti L
    Prog Urol; 2015 May; 25(6):348-54. PubMed ID: 25804429
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcomes of colorectal anastomoses during pelvic exenteration for gynaecological malignancy.
    Lim SW; Lim SB; Park JY; Park SY; Choi HS; Jeong SY
    Br J Surg; 2008 Jun; 95(6):770-3. PubMed ID: 18418859
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pelvic exenteration, University of Michigan: 100 patients at 5 years.
    Morley GW; Hopkins MP; Lindenauer SM; Roberts JA
    Obstet Gynecol; 1989 Dec; 74(6):934-43. PubMed ID: 2586960
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Survival after pelvic exenteration for T4 rectal cancer.
    Kusters M; Austin KK; Solomon MJ; Lee PJ; Nieuwenhuijzen GA; Rutten HJ
    Br J Surg; 2015 Jan; 102(1):125-31. PubMed ID: 25451182
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term clinical outcome of pelvic exenteration in patients with advanced gynecological malignancies.
    Fotopoulou C; Neumann U; Kraetschell R; Schefold JC; Weidemann H; Lichtenegger W; Sehouli J
    J Surg Oncol; 2010 May; 101(6):507-12. PubMed ID: 20401918
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pelvic exenteration: a review of the Gateshead experience 1974-1992.
    Robertson G; Lopes A; Beynon G; Monaghan JM
    Br J Obstet Gynaecol; 1994 Jun; 101(6):529-31. PubMed ID: 8018644
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sacral resection with pelvic exenteration for advanced primary and recurrent pelvic cancer: a single-institution experience of 100 sacrectomies.
    Milne T; Solomon MJ; Lee P; Young JM; Stalley P; Harrison JD; Austin KK
    Dis Colon Rectum; 2014 Oct; 57(10):1153-61. PubMed ID: 25203370
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Total pelvic exenteration as a therapeutic option in advanced malignant disease of the pelvis.
    Kraybill WG; Lopez MJ; Bricker EM
    Surg Gynecol Obstet; 1988 Mar; 166(3):259-63. PubMed ID: 3344455
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcomes of pelvic exenteration for locally advanced primary rectal cancer: Overall survival and quality of life.
    Quyn AJ; Austin KK; Young JM; Badgery-Parker T; Masya LM; Roberts R; Solomon MJ
    Eur J Surg Oncol; 2016 Jun; 42(6):823-8. PubMed ID: 26947962
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pelvic exenteration for T4 rectal cancer: a series of 15 ressectable cases].
    Costa SR; Antunes RC; Paula RP; Pedroso MA; Farah JF; Lupinacci RA
    Arq Gastroenterol; 2007; 44(4):284-8. PubMed ID: 18317645
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pelvic exenteration for gynaecological tumours: achievements and unanswered questions.
    Höckel M; Dornhöfer N
    Lancet Oncol; 2006 Oct; 7(10):837-47. PubMed ID: 17012046
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Social deprivation in patients requiring pelvic exenterative surgery.
    Radwan RW; Coyne PE; Jones HG; Evans MD; Davies M; Harris DA; Beynon J
    Colorectal Dis; 2016 Jul; 18(7):684-7. PubMed ID: 26773422
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pelvic exenteration for recurrent squamous cell carcinoma of the pelvic organs arising from the cloaca--a single institution's experience over 16 years.
    Tan KK; Pal S; Lee PJ; Rodwell L; Solomon MJ
    Colorectal Dis; 2013; 15(10):1227-31. PubMed ID: 23714581
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.